3-nitro-4-[[4-(2-oxolanylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]benzamide : no description available [CHeBI]
Assay ID | Title | Year | Journal | Article |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
albendazole | | aryl sulfide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | anthelminthic drug; microtubule-destabilising agent; tubulin modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azathioprine | | aryl sulfide; C-nitro compound; imidazoles; thiopurine | antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bithionol | | aryl sulfide; bridged diphenyl antifungal drug; bridged diphenyl fungicide; dichlorobenzene; organochlorine pesticide; polyphenol | antifungal agrochemical; antiplatyhelmintic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenbendazole | | aryl sulfide; benzimidazoles; carbamate ester | antinematodal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methiothepin | | aryl sulfide; dibenzothiepine; N-alkylpiperazine; tertiary amino compound | antipsychotic agent; dopaminergic antagonist; geroprotector; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(ethoxymethyl)-5-isopropyl-6-(phenylsulfanyl)uracil | | aryl sulfide; pyrimidone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-bis[amino-[(2-aminophenyl)thio]methylidene]butanedinitrile | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pirinixic acid | | aryl sulfide; organochlorine compound; pyrimidines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fentichlor | | aryl sulfide; bridged diphenyl antifungal drug; monochlorobenzenes; polyphenol | antiinfective agent; drug allergen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylphenylsulfide | | aryl sulfide; benzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diphenyl sulfide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methiocarb | | aryl sulfide; carbamate ester; methyl sulfide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; molluscicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pipazethate | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butoconazole nitrate | | aryl sulfide; conazole antifungal drug; imidazole antifungal drug; imidazoles; organic nitrate salt | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butoconazole | | aryl sulfide; conazole antifungal drug; dichlorobenzene; imidazole antifungal drug; imidazoles; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenticonazole | | aryl sulfide; dichlorobenzene; ether; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nelfinavir | | aryl sulfide; benzamides; organic heterobicyclic compound; phenols; secondary alcohol; tertiary amino compound | antineoplastic agent; HIV protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine | | aryl sulfide; primary alcohol; pyrimidone | antiviral drug; HIV-1 reverse transcriptase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
anpirtoline | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azintamid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiazuril | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
g 25671 | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
irgarol 1051 | | aryl sulfide; cyclopropanes; diamino-1,3,5-triazine | antifouling biocide; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-((4-chlorophenyl)thio)cyclic-3',5'-amp | | 3',5'-cyclic purine nucleotide; adenyl ribonucleotide; aryl sulfide; organochlorine compound | protein kinase agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zofenopril | | aryl sulfide; L-proline derivative; N-acyl-L-amino acid; thioester | anticonvulsant; apoptosis inhibitor; cardioprotective agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bnps-skatole | | aryl sulfide; bromoindole; C-nitro compound | reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(Ethylthio)-1,3,4-thiadiazol-2-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(s-glutathionyl)hydroquinone | | aryl sulfide; glutathione conjugate; hydroquinones | human xenobiotic metabolite; nephrotoxic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-s-cysteinyldopa | | amino dicarboxylic acid; aryl sulfide; catechols; diamine; L-tyrosine derivative; S-conjugate; S-organyl-L-cysteine | human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-3-(phenylthio)pyrazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(prop-2-enylthio)-5-thiophen-2-yl-1H-1,2,4-triazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(4-chlorophenyl)methylthio]-1,3,4-thiadiazol-2-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pd 173955 | | aryl sulfide; dichlorobenzene; methyl sulfide; pyridopyrimidine | tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methyl-2-(methylthio)-N-phenyl-5-prop-2-enyl-4-pyrimidinamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[3-cyano-6-(2-furanyl)-4-(trifluoromethyl)-2-pyridinyl]thio]propanoic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N-di(propan-2-yl)-2-[(1-propyl-5-tetrazolyl)thio]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4,6-dimethyl-2-pyrimidinyl)thio]-N,N-dimethylpropanamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2,5-dimethylphenyl)methylthio]-5-(3-pyridinyl)-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(2-furanyl)-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]-1-(4-morpholinyl)ethanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N-diethyl-2-[(3-thiophen-2-yl-7-isothiazolo[4,5-d]pyrimidinyl)thio]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[3-cyano-6-cyclopropyl-4-(trifluoromethyl)-2-pyridinyl]thio]acetic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(3-cyano-4,6-dimethyl-2-pyridinyl)thio]-3-oxobutanoic acid propan-2-yl ester | | aryl sulfide; isopropyl ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-[[2-(3-chloroanilino)-4-thiazolyl]methyl]-4-(3-methoxypropyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(6-amino-3,5-dicyano-4-thiophen-2-yl-2-pyridinyl)thio]-N-(2-phenylethyl)acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-tert-butyl-3-cyclohexyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3-cyano-6-cyclopropyl-4-thiophen-2-yl-2-pyridinyl)thio]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | | aryl sulfide; benzenes; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(Phenylthio)nicotinic acid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(2-Chloro-6-fluorobenzyl)thio]-1,3,4-thiadiazol-2-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-fluorophenyl)methylthio]-5-(4-methylphenyl)-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-fluorophenyl)methylthio]-5-(2-methylphenyl)-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(6-amino-3,5-dicyano-2-pyridinyl)thio]acetic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-bromophenyl)methylthio]-5-(3-pyridinyl)-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
GS4012 free base | | aryl sulfide; monomethoxybenzene; pyridines | VEGF activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-methylpropylthio)-1H-1,2,4-triazol-5-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3-fluorophenyl)methylthio]pyrimidine-4,6-diamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-4-(ethylthio)-6-(1-pyrrolidinyl)pyrimidine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-chlorophenyl)methylthio]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2-methylphenyl)methyl]-2-[(4-methylphenyl)thio]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N-dimethyl-3-[(4-methylphenyl)thio]propanamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(2-chloro-6-fluorophenyl)methylthio]-4-ethyl-5-(2-furanyl)-1,2,4-triazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-cyclohexyl-5-(phenylmethylthio)-1,2,4-triazol-4-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N-dimethyl-2-[(2-phenyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)thio]ethanamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-4-[(1-ethyl-2-benzimidazolyl)thio]aniline | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[3-cyano-6-(2-furanyl)-4-(trifluoromethyl)-2-pyridinyl]thio]-N,N-diethylacetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-chlorophenyl)thio]-N-(5-oxo-1-phenyl-4H-pyrazol-3-yl)acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(1,3-benzothiazol-2-ylthio)-4-hydroxyphenyl]-4-chlorobenzenesulfonamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[5-[(4-chlorophenyl)methylthio]-1,3,4-oxadiazol-2-yl]-1-(phenylmethyl)-2-pyridinone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(3-methylphenyl)thio]-2-phenyl-5-pyrimidinecarboxylic acid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-phenyl-5-[(phenylthio)methyl]isoxazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(4-chlorophenyl)-5-[(phenylthio)methyl]isoxazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[4-ethyl-5-[(4-methylphenyl)methylthio]-1,2,4-triazol-3-yl]-1-phenyl-4-pyridazinone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[3-[(4-methylphenyl)methoxy]-2-thiophenyl]-3-(methylthio)-1H-1,2,4-triazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxy-4-[(2-methoxyphenyl)thio]-2-phenylpyrimidine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4-ethylsulfonyl-2-nitrophenyl)thio]-4-methyl-1,2,4-triazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[1-oxo-2-[[5-(phenylmethylthio)-1,3,4-thiadiazol-2-yl]thio]ethyl]amino]-3-phenylthiourea | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-(dimethylamino)-3,4-dihydro-2H-pyrimido[2,1-b][1,3]thiazin-6-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[4-[(3,4-dichlorophenyl)thio]-3-pyridinyl]sulfonyl]-3-propylurea | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N-dimethyl-3-[(2-phenyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)thio]-1-propanamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-tert-butyl-4-[(4-chlorophenyl)thio]-5-methyl-1H-pyrazol-3-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzoic acid [2-oxo-2-[2-(phenylthio)anilino]ethyl] ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-[[[5-(2,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-phenyl-5-(propan-2-ylthio)-1,3,4-thiadiazol-2-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(6-amino-3,5-dicyano-4-thiophen-2-yl-2-pyridinyl)thio]acetic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-3-[3-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]propylthio]-1H-1,2,4-triazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[(2-methylphenyl)methylthio]ethyl]-3-[(4-methylphenyl)thio]propanamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dimethyl-5-[[5-(phenylthio)-2-furanyl]methylidene]-1,3-diazinane-2,4,6-trione | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-benzothiazol-2-yl)-4-[(4-fluorophenyl)thio]-5-methyl-3-pyrazolamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4,6-dimethyl-2-pyrimidinyl)-4-[(4-fluorophenyl)thio]-5-methyl-3-pyrazolamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(2-fluoroanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-furanylmethyl)acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-furanyl)-2-(1H-1,2,4-triazol-5-ylthio)ethanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-phenylthieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-N-[4-[(3,4-dimethylphenyl)thio]phenyl]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3,4-dimethylphenyl)thio]-3-pyridinecarboxylic acid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[6-amino-2,4-dioxo-1-(phenylmethyl)-5-pyrimidinyl]-2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-methylacetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1H-pyrrol-2-yl)ethanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-tert-butyl-2-[[4-(4-fluorophenyl)-2-thiazolyl]thio]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-5-[[(4-methyl-2-thiazolyl)thio]methyl]-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-phenyl-n-acetylcysteine | | aryl sulfide; S-substituted N-acetyl-L-cysteine | biomarker; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-2-(4-chlorophenyl)-6-(methylthio)pyrimidine-5-carbonitrile | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[3,5-Bis(methylsulfanyl)-4-isothiazolyl]methanol | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bi-78d3 | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-chlorophenyl)thio]-1-methyl-3-indolecarboxaldehyde | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(3-chlorophenyl)methyl]-3-[5-(methylthio)-1,3,4-oxadiazol-2-yl]-2-pyridinone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-methylphenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)thio]propanoic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)thio]butanedioic acid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-{2-[(4-amino-5-cyano-2-pyrimidinyl)sulfanyl]acetyl}-N'-phenylurea | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[5-[(3-chlorophenyl)thio]-2-thiophenyl]pyridine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-{5-[2-(Phenylthio)acetyl]-2-thienyl}acetic acid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[5-[2-[(4-methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[2-methyl-5-nitro-3-(phenylmethyl)-4-imidazolyl]thio]-6-nitro-1H-benzimidazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-furanyl)-2-[(1-methyl-5-tetrazolyl)thio]ethanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
u 0126 | | aryl sulfide; dinitrile; enamine; substituted aniline | antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zofenoprilate | | aryl sulfide; L-proline derivative; N-acyl-L-amino acid; thiol | anticonvulsant; apoptosis inhibitor; cardioprotective agent; drug metabolite; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vx-745 | | aryl sulfide; dichlorobenzene; difluorobenzene; pyrimidopyridazine | anti-inflammatory drug; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-methyl-2-[[3-[2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2-dimethyl-N-[2,2,2-trichloro-1-(2-pyrimidinylthio)ethyl]propanamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-4-[(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)-[4-(methylthio)phenyl]methyl]-1,2-dihydropyrazol-3-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-[(2-pyridinylthio)methyl]-4-triazolecarboxylic acid propan-2-yl ester | | aryl sulfide; azole; isopropyl ester; oxadiazole; pyridines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-cyano-3-[(2-methoxy-2-oxoethyl)thio]-5-isothiazolyl]thio]acetic acid ethenyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]ethanol | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-4-[5-methyl-2-(methylthio)-3-thiophenyl]-5-oxo-1-(3-pyridinyl)-4,6,7,8-tetrahydroquinoline-3-carbonitrile | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-methoxyphenyl)-4-[(4-methylphenyl)thio]-6-oxo-3-pyridazinecarboxylic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(phenylthio)-1-(1-pyrrolidinyl)-1-propanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gw 7647 | | aryl sulfide; monocarboxylic acid; ureas | PPARalpha agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-methyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl)thio]acetic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[7-methyl-4-(phenylthio)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]methyl]morpholine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(4-chlorophenyl)-5-sulfanylidene-1,3,4-thiadiazol-2-yl]thio]-N-(1,1-dioxo-3-thiolanyl)-N-(2-methylpropyl)acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l 663536 | | aryl sulfide; indoles; monocarboxylic acid; monochlorobenzenes | antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; leukotriene antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)thio]propanoic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(3-cyano-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl)thio]-3-oxobutanoic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[[(4-chlorophenyl)thio]methyl]-2-methyl-1H-pyrazol-3-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-azepanyl)-2-[(5-methyl-4-nitro-1H-pyrazol-3-yl)thio]ethanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-adamantyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-nitro-3-pyridinyl)oxy]-N-[2-(phenylthio)phenyl]acetamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-amino-4-[(4-chlorophenyl)thio]benzoic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(3-nitro-2-pyridinyl)thio]-N-prop-2-enyl-1,3,4-thiadiazol-2-amine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(prop-2-enylthio)-[1,2,4]triazino[5,6-d][3,1]benzoxazepine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulindac sulfide | | aryl sulfide; monocarboxylic acid; organofluorine compound | antineoplastic agent; apoptosis inducer; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinanserin | | aryl sulfide; cinnamamides; secondary carboxamide; tertiary amino compound | anticoronaviral agent; antiviral agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(2-chlorophenyl)thio]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylic acid ethyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-oxolanylmethylthio)-5,6-diphenyl-1,2,4-triazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
axitinib | | aryl sulfide; benzamides; indazoles; pyridines | antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-methyl-5-(2-phenylethyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-[(4-chlorophenyl)methylthio]-3-methyl-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-[(3-chlorophenyl)methylthio]-3-methyl-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-7-[(3-methylphenyl)methylthio]-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(ethylthio)-6-(2-furanyl)pyridazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(3-fluorophenyl)methylthio]-6-(2-furanyl)pyridazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4-bromophenyl)methylthio]-6-(2-furanyl)pyridazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4-chlorophenyl)methylthio]-6-(2-furanyl)pyridazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-chlorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gw 501516 | | 1,3-thiazoles; aromatic ether; aryl sulfide; monocarboxylic acid; organofluorine compound | carcinogenic agent; PPARbeta/delta agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(4-methylphenyl)thio]-2-thieno[2,3-c]pyridinecarboxamide | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cangrelor | | adenosine 5'-phosphate; aryl sulfide; nucleoside triphosphate analogue; organochlorine compound; organofluorine compound; secondary amino compound | P2Y12 receptor antagonist; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[2-[[2-[(dimethylamino)methyl]phenyl]thio]-5-iodophenyl]methanol | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ticagrelor | | aryl sulfide; hydroxyether; organofluorine compound; secondary amino compound; triazolopyrimidines | P2Y12 receptor antagonist; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vortioxetine | | aryl sulfide; N-arylpiperazine | antidepressant; anxiolytic drug; serotonergic agonist; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n-dimethyl-2-(2-amino-4-fluorophenylthio)benzylamine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-737 | | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay 60-6583 | | aminopyridine; aromatic ether; aryl sulfide; cyanopyridine; cyclopropanes; monocarboxylic acid amide | adenosine A2B receptor agonist; anti-inflammatory agent; cardioprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(3-methylphenyl)methylthio]-6-thiophen-2-ylpyridazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[5-(4-ethylanilino)-1,3,4-thiadiazol-2-yl]thio]-2-oxolanone | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(3-pyridinylmethylthio)-6-thiophen-2-ylpyridazine | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sgx 523 | | aryl sulfide; biaryl; pyrazoles; quinolines; triazolopyridazine | c-Met tyrosine kinase inhibitor; nephrotoxic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
navitoclax | | aryl sulfide; monochlorobenzenes; morpholines; N-sulfonylcarboxamide; organofluorine compound; piperazines; secondary amino compound; sulfone; tertiary amino compound | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-methoxyphenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-bromophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-methoxyphenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-methoxyphenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-fluorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-bromophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-bromophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-chlorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[4-[(1-methyl-5-tetrazolyl)thio]-5-thieno[2,3-d]pyrimidinyl]benzonitrile | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-(4-nitrophenyl)thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(1,3-benzodioxol-5-yl)-4-(1-methyltetrazol-5-yl)sulfanylthieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-(3-thiophenyl)thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-benzofuranyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-(1H-pyrrol-2-yl)thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-methylsulfonylphenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(1-methyl-5-tetrazolyl)thio]-5-(1-naphthalenyl)thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine | | aryl sulfide; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monepantel | | (trifluoromethyl)benzenes; aromatic ether; aryl sulfide; nitrile; secondary carboxamide | anthelminthic drug; nematicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lesinurad | | aryl sulfide; cyclopropanes; monocarboxylic acid; naphthalenes; organobromine compound; triazoles | uricosuric drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(methylthio)-6-(phenylmethyl)-1H-pyrimidin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-2-methylsulfanyl-6-propyl-1H-pyrimidin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-((4-chlorophenyl)thio)cyclic-3',5'-gmp | | 3',5'-cyclic purine nucleotide; aryl sulfide; organochlorine compound; ribonucleotide | protein kinase agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
febantel | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(butylthio)-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-phenylethylthio)-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | | aryl sulfide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |